Rockefeller Capital Management L.P. Cytosorbents Corp Transaction History
Rockefeller Capital Management L.P.
- $47.9 Billion
- Q3 2025
A detailed history of Rockefeller Capital Management L.P. transactions in Cytosorbents Corp stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 1,000 shares of CTSO stock, worth $700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$700% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC5.08MShares$3.56 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.2MShares$1.54 Million0.0% of portfolio
-
Skylands Capital, LLC2.13MShares$1.49 Million0.31% of portfolio
-
Neuberger Berman Group LLC New York, NY1.6MShares$1.12 Million0.0% of portfolio
-
Cm Management, LLC1.29MShares$901,6891.12% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $30.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...